Aaron Brown, PharmD

Education

2019 PharmD, Butler University, Indianapolis, IN

 

Bio

Dr. Aaron Brown received his Doctor of Pharmacy from Butler University in Indianapolis, IN, in 2019. He worked as a pharmacist in the Bloomington, IN, region before completing his PGY-1 Pharmacy Residency at Veteran Health Indiana in Indianapolis, IN, in 2023 an 2024, respectively.

 

Dr. Brown currently practices as a Clinical Pharmacist at Fort Collins Family Medicine Center, seeing patients for primary care disease state management. His practice and research interests include pharmacy practice advancement, anticoagulation, and transactions.

 

Research Synopsis
Dr. Aaron Brown’s research focuses on optimizing pharmacotherapy and care transitions through pharmacist-led interventions, with an emphasis on anticoagulation, infectious disease, and chronic disease management. His recent publications include a cost analysis of single-dose intravenous antibiotics in the emergency department (Journal of the American Pharmacists Association, 2024) and commentary on pharmacist roles in care transitions (Journal of the American College of Clinical Pharmacy, 2023).

He has presented nationally and regionally on anticoagulation stewardship, periprocedural management of direct oral anticoagulants, and ambulatory care pharmacy’s role in care coordination. His current projects include a retrospective analysis of anticoagulation clinic recommendations for GI procedures, comparisons of pharmacist-led phone versus in-person diabetes visits, and the use of proactive “cold calls” to close patient care gaps. He also studies predictors of pharmacy school admissions through letters of recommendation analysis.

Collectively, Dr. Brown’s scholarship advances pharmacist-driven models of care that strengthen medication safety, reduce preventable complications, and improve chronic disease outcomes, particularly in Veterans Health systems.

 

Short Highlight 
Dr. Aaron Brown’s research improves patient outcomes through pharmacist-led interventions in anticoagulation, infectious diseases, and chronic disease management. His projects focus on safe transitions of care and innovative patient outreach models.